These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

728 related articles for article (PubMed ID: 25796566)

  • 1. mTOR signaling in aging and neurodegeneration: At the crossroad between metabolism dysfunction and impairment of autophagy.
    Perluigi M; Di Domenico F; Butterfield DA
    Neurobiol Dis; 2015 Dec; 84():39-49. PubMed ID: 25796566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinase mTOR: regulation and role in maintenance of cellular homeostasis, tumor development, and aging.
    Parkhitko AA; Favorova OO; Khabibullin DI; Anisimov VN; Henske EP
    Biochemistry (Mosc); 2014 Feb; 79(2):88-101. PubMed ID: 24794724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of PI3K/AKT/mTOR pathway in the modulation of autophagy and the clearance of protein aggregates in neurodegeneration.
    Heras-Sandoval D; Pérez-Rojas JM; Hernández-Damián J; Pedraza-Chaverri J
    Cell Signal; 2014 Dec; 26(12):2694-701. PubMed ID: 25173700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of autophagy by mTOR-dependent and mTOR-independent pathways: autophagy dysfunction in neurodegenerative diseases and therapeutic application of autophagy enhancers.
    Sarkar S
    Biochem Soc Trans; 2013 Oct; 41(5):1103-30. PubMed ID: 24059496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. mTOR Signaling in Growth, Metabolism, and Disease.
    Saxton RA; Sabatini DM
    Cell; 2017 Mar; 168(6):960-976. PubMed ID: 28283069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. mTOR in Brain Physiology and Pathologies.
    Bockaert J; Marin P
    Physiol Rev; 2015 Oct; 95(4):1157-87. PubMed ID: 26269525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monitoring mammalian target of rapamycin (mTOR) activity.
    Ikenoue T; Hong S; Inoki K
    Methods Enzymol; 2009; 452():165-80. PubMed ID: 19200882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. mTOR in Alzheimer disease and its earlier stages: Links to oxidative damage in the progression of this dementing disorder.
    Perluigi M; Di Domenico F; Barone E; Butterfield DA
    Free Radic Biol Med; 2021 Jun; 169():382-396. PubMed ID: 33933601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. mTOR in aging, metabolism, and cancer.
    Cornu M; Albert V; Hall MN
    Curr Opin Genet Dev; 2013 Feb; 23(1):53-62. PubMed ID: 23317514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.
    Ryskalin L; Limanaqi F; Frati A; Busceti CL; Fornai F
    Int J Mol Sci; 2018 Jul; 19(8):. PubMed ID: 30061532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mammalian target of rapamycin (mTOR) as a potential therapeutic target in various diseases.
    Kaur A; Sharma S
    Inflammopharmacology; 2017 Jun; 25(3):293-312. PubMed ID: 28417246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic control by target of rapamycin and autophagy during ageing - a mini-review.
    Markaki M; Tavernarakis N
    Gerontology; 2013; 59(4):340-8. PubMed ID: 23594965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mammalian target of rapamycin and tuberous sclerosis complex.
    Wataya-Kaneda M
    J Dermatol Sci; 2015 Aug; 79(2):93-100. PubMed ID: 26051878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of mTOR in age-related diseases.
    Chrienova Z; Nepovimova E; Kuca K
    J Enzyme Inhib Med Chem; 2021 Dec; 36(1):1679-1693. PubMed ID: 34309456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Triangle of Death in Alzheimer's Disease Brain: The Aberrant Cross-Talk Among Energy Metabolism, Mammalian Target of Rapamycin Signaling, and Protein Homeostasis Revealed by Redox Proteomics.
    Di Domenico F; Barone E; Perluigi M; Butterfield DA
    Antioxid Redox Signal; 2017 Mar; 26(8):364-387. PubMed ID: 27626216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Moving to the Rhythm with Clock (Circadian) Genes, Autophagy, mTOR, and SIRT1 in Degenerative Disease and Cancer.
    Maiese K
    Curr Neurovasc Res; 2017; 14(3):299-304. PubMed ID: 28721811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Mechanistic Target of Rapamycin: The Grand ConducTOR of Metabolism and Aging.
    Kennedy BK; Lamming DW
    Cell Metab; 2016 Jun; 23(6):990-1003. PubMed ID: 27304501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mammalian target of rapamycin and the kidney. I. The signaling pathway.
    Lieberthal W; Levine JS
    Am J Physiol Renal Physiol; 2012 Jul; 303(1):F1-10. PubMed ID: 22419691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Longevity Pathways (mTOR, SIRT, Insulin/IGF-1) as Key Modulatory Targets on Aging and Neurodegeneration.
    Mazucanti CH; Cabral-Costa JV; Vasconcelos AR; Andreotti DZ; Scavone C; Kawamoto EM
    Curr Top Med Chem; 2015; 15(21):2116-38. PubMed ID: 26059361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel compounds for the modulation of mTOR and autophagy to treat neurodegenerative diseases.
    Heras-Sandoval D; Pérez-Rojas JM; Pedraza-Chaverri J
    Cell Signal; 2020 Jan; 65():109442. PubMed ID: 31639492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.